Acne vulgaris management: what’s new and what’s still true?
Keywords:
Acne, Pimples, Tretinoin, Benzoyl peroxide, Antibiotics, RetinoidsAbstract
Acne vulgaris is one of the commonest skin disorders that can affect individuals from childhood to adulthood, most often occurring in the teenage years. Regarding its management, what’s still true is that a wide range of treatment options are available, ranging from the commonly used topical treatments like benzoyl peroxide, azelaic acid, sulfur, antibiotics, retinoids and superficial chemical peels while the systemic treatments available include the use of systemic antibiotics, retinoids, and antiandrogens. What’s new in the management of acne vulgaris is the use of laser and light devices and other newer technologies. The present article reviews the use of above mentioned agents in the current scenario.
References
Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol. 2009;129:2480-8.
Simpson NB, Cunliffe WJ. Disorders of the sebaceous glands. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Text Book of Dermatology. 7th ed. US: Blackwell Science; 2004: 43.1-43.75.
Gregory AC, Smith C, Kerry ME, Wheatley ER, Bolwell GP. Comparative subcellular immunolocation of polypeptides associated with xylan and callose synthases in French bean (Phaseolus vulgaris) during secondary wallformation. Phytochemistry. 2002;59:249-59.
Rathi SK. Acne vulgaris treatment: the current scenario. Indian J Dermatol. 2011;56:7-13.
Leyden JJ. New understanding of the pathogenesis of acne. J Am Acad Dermatol. 1995;32:515-25.
Keri J, Shiman M. An update on the management of acne vulgaris. Clin Cosm Investigat Dermatol. 2014;2:105-10.
Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49:200-10.
Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol. 1994;131:331-6.
Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol. 2000;43:47-50.
Russell JJ. Topical therapy for acne. Am Fam Physician. 2000;61:357-66.
Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother. 2005;6:409-18.
El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, et al. Chronic minocycline-induced autoimmunity in children. J Pediatr. 2008;153:314-9.
Bowe WP, Hoffstad O, Margolis DJ. Upper respiratory tract infection in household contacts of acne patients. Dermatology. 2007;215:213-8.
Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J, et al. Effects of subantimicrobialdose doxycycline in the treatment of moderate acne. Arch Dermatol. 2003;139:459-64.
Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. Cutis. 2008;81:405-8.
Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, et al. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002;138:481-9.
Givre SJ, Fleischman D. Intracranial hypertension in a patient using topical adapalene. J Neuroophthalmol. 2008;28:156-8.
Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skin Med. 2005;4:138-46.
Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3:24-38.
Hassanzadeh P, Bahmani M, Mehrabani D. Bacterial resistance to antibiotics in acne vulgaris: an in vitro study. Indian J Dermatol. 2008;53:122-4.
Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2007;26:210-20.
Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Eng J Med. 1985;313:837-41.
Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag. 2008;4:487-92.
Skin Laboratory. Superficial peels, 2014. Available at: http://www.skinlaboratory.com/videos/superficial-peels/. Accessed 22 December 2014.
Kessler E, Flanagan K, Chia C, Rogers C, Glaser DA. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg. 2008;34:45-50.
Sharad J. Combination of microneedling and glycolic acid peels for the treatment of acne scars in dark skin. J Cosmet Dermatol. 2011;10(4):317-23.
Kempiak SJ, Uebelhoer N. Superficial chemical peels and microdermabrasion for acne vulgaris. Semin Cutan Med Surg. 2008;27:212-20.
Alexiades-Armenakas M. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers. Dermatol Clin. 2007;25:25-33.
Sadick NS. Handheld LED array device in the treatment of acne vulgaris. J Drugs Dermatol. 2008;7:347-50.
Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39:180-8.
Nakatsuji T, Rasochova L, Huang CM. Vaccine therapy for P. acnes associated diseases. Infect Disord Drug Targets. 2008;8:160-5.
